Author Title [ Type(Asc)] Year
Filters: Author is He, Yi  [Clear All Filters]
Journal Article
Long B, Shan Y-L, Sun Y-L, Wang T-Y, Li X-D, Huang K, Zhang W-W, He Y, Wen R-J, Li Y-H, et al. Vitamin C promotes anti-leukemia of DZNep in acute myeloid leukemia. Biochim Biophys Acta Mol Basis Dis. 2022:166357.
Li Y, He Y, Chen G, Huang Z, Yi C, Zhang X, Deng F, Yu D. Selenomethionine protects oxidative-stress-damaged bone-marrow-derived mesenchymal stem cells via an antioxidant effect and the PTEN/PI3K/AKT pathway. Exp Cell Res. 2021:112864.
Chen J, Pang A, Zhao Y, Liu L, Ma R, Wei J, Chen X, He Y, Yang D, Zhang R, et al. Primary graft failure following allogeneic hematopoietic stem cell transplantation: risk factors, treatment and outcomes. Hematology. 2022;27(1):293-299.
Zhang S, Zhang P, Wang Z, Liu L, He Y, Jiang E, Wei J, Yang D, Zhang R, Zhai W, et al. Posaconazole oral suspension as salvage therapy for invasive fungal disease in patients with hematological diseases. Future Microbiol. 2019.
Cai X, Wei J, He Y, Yang D, Jiang E, Huang Y, Han M, Feng S. A modified busulfan and cyclophosphamide preparative regimen for allogeneic transplantation in myeloid malignancies. Int J Clin Pharm. 2014.
Wang J, Wang Q, Zhang H, He Y, Huang Y, Zhang R, Wei J, Ma Q, Pang A, Yang D, et al. Moderate to severe marrow fibrosis as a more advanced risk factor for MDS and MDS-AML patients with excess of blasts receiving allogeneic hematopoietic stem cell transplantation. Transplant Cell Ther. 2021.
Alejo S, Palacios BE, Venkata PPitta, He Y, Li W, Johnson JD, Yihong C, Jayamohan S, Pratap UP, Clarke K, et al. Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double strand break repair and augments efficacy of temozolomide in glioblastoma. Neuro Oncol. 2023.
Zhang X, Wang J, Liu Y, Liu J, Wang B, Zhang Q, Guan W, Zhang H, Xu L, Liu G, et al. Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation. J Transl Med. 2022;20(1):596.
He Y, Li H, Zhang F, Zhang G, Tang X, Zhu T, Huang N, Li X. Immunotherapeutic effects of lymphocytes co-cultured with human cord blood-derived multipotent stem cells transplantation on APP/PS1 mice. Behav Brain Res. 2016.
Zhao F, Shi Y, Chen X, Zhang R, Pang A, Zhai W, Yang D, He Y, Feng S, Zhang P, et al. Higher Dose of CD34 cells Promotes Early Reconstitution of Natural Killer Cells and Is Associated with Better Outcomes After Unmanipulated Hematopoietic Stem Cell Transplantation for Myeloid Malignancies. Transplant Cell Ther. 2022.
Ren E, Chen H, Qin Z, Guan S, Jiang L, Pang X, He Y, Zhang Y, Gao X, Chu C, et al. Harnessing Bifunctional Ferritin with Kartogenin Loading for Mesenchymal Stem Cell Capture and Enhancing Chondrogenesis in Cartilage Regeneration. Adv Healthc Mater. 2022:e2101715.
Li T, Jin W, He Y, Zhou Z. Generation of PRMT6 homozygous knockout human embryonic stem cell lines. Stem Cell Res. 2020;50:102136.
Zhang X, Wei C, Li Y, Li Y, Chen G, He Y, Yi C, Wang C, Yu D. Dose-dependent cytotoxicity induced by pristine graphene oxide nanosheets for potential bone tissue regeneration. J Biomed Mater Res A. 2019.
Cao Y-G, He Y, Zhang S-D, Liu Z-X, Zhai W-H, Ma Q-L, Pang A-M, Wei J-L, Yang D-L, Huang Y, et al. Conditioning regimen of 5-day decitabine administration for allogeneic stem cell transplantation in patients with myelodysplastic syndrome and myeloproliterative neoplasms. Biol Blood Marrow Transplant. 2019.
He Y, Li Y, Chen G, Wei C, Zhang X, Zeng B, Yi C, Wang C, Yu D. Concentration-dependent cellular behavior and osteogenic differentiation effect induced in bone marrow mesenchymal stem cells treated with magnetic graphene oxide. J Biomed Mater Res A. 2019.
Cao Y, Gong X, Feng Y, Wang M, Hu Y, Liu H, Liu X, Qi S, Ji Y, Liu F, et al. The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases. Am J Hematol. 2023.
Long Z-J, Hu Y, Li X-D, He Y, Xiao R-Z, Fang Z-G, Wang D-N, Liu J-J, Yan J-S, Huang R-W, et al. ATO/ATRA/Anthracycline-Chemotherapy Sequential Consolidation Achieves Long-Term Efficacy in Primary Acute Promyelocytic Leukemia. PLoS One. 2014;9(8):e104610.